Johnson & Johnson agreed to resolve criminal and civil probes into the marketing of Risperdal, an antipsychotic drug, and other medicines by paying more than $2.2 billion, one of the largest U.S. health-fraud penalties.
Dentons LLP, the 2,600-lawyer global law firm, and McKenna Long & Aldridge LLP, a 575-lawyer firm, will put their proposed merger to a vote of partners in the next two weeks, both firms confirmed in an e-mail.
Johnson & Johnson’s Janssen Pharmaceuticals failed to inform expectant mothers of risks that its epilepsy drug Topamax could cause birth defects, a lawyer for the mother of a Virginia 6-year-old told a jury.
A South Carolina judge today deferred a decision on the penalties he will impose on a Johnson & Johnson unit for violating consumer-protection laws in a case in which the attorney general seeks billions of dollars.
AstraZeneca Plc and affiliates will pay as much as $11 million to settle claims the company violated antitrust and consumer-protection laws by keeping generic versions of the heart drug Toprol XL off the market.